Cancer Research Cell Death Mechanisms and Cancer Therapy  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 4537, May 15, 2007. doi: 10.1158/0008-5472.CAN-07-0391
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuehn, E. W.
Right arrow Articles by Benzing, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kuehn, E. W.
Right arrow Articles by Benzing, T.
Related Collections
Right arrow Cellular Pathobiology
Right arrow Cellular Pathobiology: Cancer Genes and Genomics
Right arrow Cellular Pathobiology: Proliferation, Senescence, and Death

Review

von Hippel-Lindau: A Tumor Suppressor Links Microtubules to Ciliogenesis and Cancer Development

E. Wolfgang Kuehn1, Gerd Walz1 and Thomas Benzing2

1 Renal Division, University Hospital Freiburg, Freiburg, Germany and 2 Department of Medicine IV, University of Cologne, Cologne, Germany

Requests for reprints: Thomas Benzing, Department of Medicine IV, University of Cologne, Kerpener Strasse 62, D-50924 Köln, Germany. Phone: 49-221-478-4480; Fax: 49-221-478-5959; E-mail: thomas.benzing{at}uk-koeln.de.

Loss of von Hippel-Lindau (VHL) tumor suppressor gene function occurs in familial and most sporadic renal cell carcinoma. The tumor suppressor role of the protein pVHL is based on its ability to target transcription factors of the hypoxia-inducible factor family for degradation, but other functions of pVHL are less clearly defined. New findings show that pVHL is necessary for cilia formation. pVHL interacts with PAR proteins, a complex that specifies the membrane domains of polarized epithelial cells, and directs the orientation of growing microtubules. Loss of pVHL results in aberrant orientation of newly formed microtubules and prevents ciliogenesis. These results add to a growing body of evidence linking cilia and the cell cycle and suggest that the tumor suppressor role of pVHL may involve previously unrecognized pathways. [Cancer Res 2007;67(10):4537–40]




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Yang, J. Bai, R. Shen, S. A.N. Brown, E. Komissarova, Y. Huang, N. Jiang, G. F. Alberts, M. Costa, L. Lu, et al.
Polo-like Kinase 3 Functions as a Tumor Suppressor and Is a Negative Regulator of Hypoxia-Inducible Factor-1{alpha} under Hypoxic Conditions
Cancer Res., June 1, 2008; 68(11): 4077 - 4085.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. M. O'Neill, S. Seo, I. G. Serebriiskii, S. R. Lessin, and E. A. Golemis
A New Central Scaffold for Metastasis: Parsing HEF1/Cas-L/NEDD9
Cancer Res., October 1, 2007; 67(19): 8975 - 8979.
[Abstract] [Full Text] [PDF]


Home page
CRO ContentHome page
G. C. Prendergast
Biological research in cancer: Convergent versus divergent problems
Cancer Reviews Online Content, June 1, 2007; 2007(3): 5 - 6.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.